Page 52 - Pharma

Dr Reddy's approaches US FDA for three new drugs

The three new drug applications are in support of Dr Reddy's proprietary products group, focused on developing and commercialising therapies in dermatology and neurology

Mylan proposes to buy Perrigo in a $29 bn cash & stock deal

The deal, if materialises, would led to creation of a pharma company having interest in specialty brands, generics, over-the-counter (OTC) and nutritional products

Glenmark Generics settles pricing investigation in Texas; Agrees to pay $25 mn

As a part of the agreement with Texas Attorney General, Glenmark's arm will make a payment in 16 equal instalments of $1.56 mn each quarter over next four years to the state of Texas

Glenmark receives US FDA approval for FemHRT generic

The company has received final ANDA approval for norethindrone acetate and ethinyl estradiol tablets

USFDA grants approval to Aurobindo Pharma's sildenafil injection

Sildenafil injection, which is generic version of Pfizer's Revatio, is indicated for the treatment of adult patients with pulmonary arterial hypertension

Caplin Point inks distribution pact with Fresenius Kabi USA

This is a product specific agreement for USA, with currently two products featuring in the contract

Ashland plans $89-mn expansion for specialty chemicals in US

The company will increase production of Natrosol hydroxyethylcellulose and Klucel hydroxypropylcellulose at Hopewell, Virginia

Merck Serono, Medicines for Malaria Venture to co-develop antimalarial drug

Both sides have signed a worldwide agreement, which grants Merck Serono the rights to the investigational antimalarial drug candidate, DDD107498

Lupin launches hypertension drug in US

The amlodipine and valsartan tablet is the generic version of Novartis' Exforge

Indoco Remedies buys Piramal Enterprises' clinical research division in Hyderabad

The acquisition is expected to help Indoco Remedies to reduce its dependence on outsourcing bio-equivalence studies and expand its R&D capabilities

Dr Reddy's acquires Belgium-based UCB's select portfolio for Rs 800 cr

With this, Dr Reddy's is expected to strengthen its presence in dermatology, respiratory and paediatrics

DSM acquires vitamin C maker Aland

The transaction excludes Aland's consumer health activities

Pluss Polymers' MiraCradle receives award for innovation in medical equipment

MiraCradle is an affordable passive cooling device which uses the advanced phase change material technology to induce therapeutic hypothermia among newborns suffering from birth asphyxia

Biomedicine, agricultural markets to give a boost to bio-based polymers

Though bio-based polymers face challenges, such as high cost, etc, they can offer advantages like biodegradability in the right target markets, according to Lux Research

Suven Life receives patents for CNS drug in Canada, Japan & Korea

These Patents are valid through 2030

D Yellow Elephant launches operation in India to serve pharma industry

The new firm aims to create meaningful and measurable interactive web marketing for the world's largest health & pharma brands and corporates

Strides Arcolab launches generic hepatitis C drug Virso

This follows a licensing agreement signed by Strides with Gilead Sciences in September 2014 to introduce hepatitis C drug, sofosbuvir, in 91 developing countries

Lupin, Rotary join hands for anti-TB campaign in Mumbai

The joint initiative would focus on detection, creating awareness, control and the eventual eradication of TB in Mumbai

Cipla's JV firm Stempeutics receives approval for stem cell drug in EU

The new treatment offers hope to patients suffering from Thromboangiitis Obliterans (Buerger's disease) affecting an estimated 2 out of every 10,000 people in Europe

Government plans to set up 10 pharma clusters

These clusters, which will provide common facilities to manufacturers, will help the industry hive off up to 25% of the cost, making them globally competitive, says Ananth Kumar